相关实验视频
Updated: Jun 19, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.6K
纳米材料的当前进展影响了血小板的功能和形态
Dongxin Peng1, Sujing Sun1, Man Zhao1
1Institute of Health Service and Transfusion Medicine, Beijing 100850, China.
Journal of functional biomaterials
|July 26, 2024
概括
纳米粒子 (NP) 与血小板相互作用,影响其功能. 了解这些相互作用对于开发更安全的纳米药物和最大限度地减少血液系统的不良影响至关重要.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 血液学 血液学 血液学
背景情况:
- 纳米材料为生物医学应用提供独特的特性,如疾病诊断和治疗.
- 纳米药物通常依赖于被动向 (EPR效应) 或主动向分子进行输送.
- 纳米药物的静脉注射需要了解纳米粒子与血液细胞的相互作用.
研究的目的:
- 审查纳米粒子 (NP) 对血小板激活,聚合,释放和亡的影响.
- 研究NP的物理和化学特性如何影响血小板相互作用.
- 阐明NP诱导的血小板激活和聚合背后的机制.
主要方法:
- 对研究纳米粒子-血小板相互作用的文献综述.
- 对NP对血小板形态和膜蛋白的影响数据的分析.
- 对NP诱导的血小板反应信息的综合.
主要成果:
- 纳米粒子可以影响血小板激活,聚合,释放和亡.
- NP的特性显著影响它们与血小板的相互作用.
- NP诱导的血小板激活和聚合的机制需要进一步研究.
结论:
- 了解NP-血小板相互作用对于减少与血液有关的不良反应至关重要.
- 在用于生物医学的纳米粒子工程过程中,考虑这些相互作用是必不可少的.
相关概念视频
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Formation of the Platelet Plug
5.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
507
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
507
Anticoagulant Drugs: Low-Molecular-Weight Heparins
663
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
663

